Efficacy of TAGRISSO® (osimertinib) in Metastatic EGFRm NSCLC
A Overall survival (OS) for the entire cohort. The median OS is... | Download Scientific Diagram
Median Survival Time - an overview | ScienceDirect Topics
Efficacy Data in Metastatic Colorectal Carcinoma | STIVARGA® (regorafenib) Global HCP Website
Clinical Trial Efficacy | NEXAVAR® (sorafenib) HCP Website
Efficacy Data | Xofigo® (Radium Ra 223 Dichloride)
Overall survival (OS) of all patients. The median OS is 26 months (95 %... | Download Scientific Diagram
Median OS vs Hazard Ratio | Stivarga Global Website
Kaplan-Meier curves for overall survival. The median overall survival... | Download Scientific Diagram
Eryaspase regimen safe, may benefit certain patients with advanced pancreatic cancer
Efficacy Data in Metastatic Colorectal Carcinoma | STIVARGA® (regorafenib) Global HCP Website
Median progression-free survival (PFS), duration of response (DOR), and... | Download Scientific Diagram
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Efficacy I PLUVICTO
Median Overall Survival (mOS) | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Kaplan-Meier plots for survivals. In Figure 2A, a median OS of 9.1... | Download Scientific Diagram
VENCLEXTA® (venetoclax tablets) | VIALE-A Trial Overall Survival Data
KarMMa Survival Rates | ABECMA® (idecabtagene vicleucel)
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters | PLOS ONE
Overall survival. Median OS was 13 months (95%Cl 9–16). | Download Scientific Diagram
BLINCYTO® Adult Efficacy | BLINCYTO® (blinatumomab)
Kaplan-Meier plot of median Os (interim analysis) (n=90).... | Download Scientific Diagram
A Overall survival (OS) for the entire cohort. The median OS is... | Download Scientific Diagram
Overall survival. Median OS was 13 months (95%Cl 9–16). | Download Scientific Diagram
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab | Journal for ImmunoTherapy of Cancer | Full Text
Avastin® (bevacizumab) Clinical Trials | CC Treatment
Overall survival (OS) analyses. Case numbers, median OS and P-values... | Download Scientific Diagram
